| Nov 13, 2025 |
Nov 17, 2025 |
FMR LLC
|
10% Owner |
Neutral |
47.5
|
-2,233,460
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 14, 2025 |
ARCH Venture Partners XII, LLC
|
Director |
Neutral |
47.5
|
-26,816,808
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Marso Steven
|
CHIEF MEDICAL OFFICER |
Neutral |
47.5
|
-17,000
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
BERNS PAUL L
|
Director |
Neutral |
47.5
|
-16,798,952
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Lang Matthew
|
CHIEF LEGAL OFFICER |
Neutral |
47.5
|
-12,500
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Population Health Partners GP, LLC
|
10% Owner |
Neutral |
47.5
|
-12,767,462
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Burow Kristina
|
Director |
Neutral |
47.5
|
-51,414,082
|
-100.00%
|
✗
|
- |
| Nov 11, 2025 |
Nov 13, 2025 |
Validae Health, L.P.
|
10% Owner |
Neutral |
27.5
|
-12,767,462
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Pinto Joshua
|
Director |
Neutral |
47.5
|
-2,688
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Stonehouse Jon P
|
Director |
Neutral |
47.5
|
-2,688
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Hubbard Brian
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
47.5
|
-17,000
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Visioli Christopher
|
CFO |
Neutral |
47.5
|
-21,250
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
MEANWELL CLIVE
|
Chair |
Neutral |
47.5
|
-12,772,837
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 13, 2025 |
Bernard Christopher Whitten
|
Officer |
Neutral |
47.5
|
-12,788,712
|
-100.00%
|
✗
|
- |
| Nov 10, 2025 |
Nov 12, 2025 |
FMR LLC
|
10% Owner |
Neutral |
27.5
|
-860,722
|
-27.82%
|
✗
|
- |
| Nov 3, 2025 |
Nov 5, 2025 |
FMR LLC
|
10% Owner |
Sell |
26.3
|
-570,085
|
-15.56%
|
✗
|
$11.8K |
| Oct 6, 2025 |
Oct 8, 2025 |
FMR LLC
|
10% Owner |
Neutral |
27.5
|
-633,715
|
-14.74%
|
✗
|
- |
| Sep 2, 2025 |
Sep 12, 2025 |
FMR LLC
|
10% Owner |
Neutral |
90.0
|
+1,107,547
|
100.00%
|
✗
|
- |
| Sep 2, 2025 |
Sep 4, 2025 |
FMR LLC
|
10% Owner |
Sell |
27.5
|
-214,847
|
-4.73%
|
✗
|
$9.6K |
| May 20, 2025 |
May 22, 2025 |
Pinto Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
MEANWELL CLIVE
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
Burow Kristina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
Visioli Christopher
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
Lang Matthew
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
Bernard Christopher Whitten
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
BERNS PAUL L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
Hubbard Brian
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 22, 2025 |
Marso Steven
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 28, 2025 |
Apr 30, 2025 |
Stonehouse Jon P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 30, 2025 |
Lang Matthew
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 30, 2025 |
Stonehouse Jon P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
FMR LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 3, 2025 |
Burow Kristina
|
Director |
Buy |
97.5
|
+2,222,222
|
9.04%
|
✗
|
$40M |
| Feb 3, 2025 |
Feb 3, 2025 |
BERNS PAUL L
|
Director |
Buy |
97.5
|
+789,998
|
9.31%
|
✗
|
$14.2M |
| Feb 3, 2025 |
Feb 3, 2025 |
ARCH Venture Partners XII, LLC
|
10% Owner |
Buy |
97.5
|
+2,222,222
|
9.04%
|
✗
|
$40M |
| Jan 30, 2025 |
Feb 3, 2025 |
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Burow Kristina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Marso Steven
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
BERNS PAUL L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Validae Health, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Visioli Christopher
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Hubbard Brian
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
MEANWELL CLIVE
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Bernard Christopher Whitten
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Pinto Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
ARCH Venture Partners XII, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 30, 2025 |
FMR LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |